Direct primary care for diabetes management works because type 2 diabetes is not an annual-visit disease. It is a disease of small adjustments made often: a metformin dose, a GLP-1 titration, a change in the numbers you see on a continuous glucose monitor. The insurance-based system, which pays for a rushed visit every three to six months, is structurally mismatched to that reality. A flat-fee direct primary care membership is built for it — same clinician, same-day access, and labs at wholesale so nobody is rationing an A1c to save a copay.

TL;DR: Direct primary care for diabetes management pairs unlimited visits, direct messaging, and wholesale-priced labs with a clinician who follows your numbers between appointments. That continuity is what moves A1c. It suits adults with prediabetes or type 2 diabetes who want frequent, low-friction adjustments instead of a 12-minute recheck twice a year. It is not a substitute for insurance covering insulin, hospital care, or specialists.

Why continuity beats frequency-of-billing

Glycemic control is a feedback loop. You change a medication or a habit, you watch the response in your glucose data and your next A1c, and you adjust again. Traditional care breaks that loop: you see whoever is available, they have 12 minutes, and the next touchpoint is months away. Direct primary care closes the loop. You message your clinician the CGM export, they respond, and the medication moves this week instead of next quarter.

The lab economics matter

An A1c, a comprehensive metabolic panel, a lipid panel, and a urine albumin-to-creatinine ratio are the backbone of diabetes monitoring. In direct primary care those labs are billed to you at wholesale — often a fraction of the retail price — so the clinician can check them when they are clinically useful rather than when a copay allows. Kidney function and lipids get watched on schedule, not skipped.

What steady diabetes care tracks
<7%
common A1c target for many adults with type 2 diabetes
every 3 months
how often A1c is typically rechecked when adjusting therapy
1 test
urine albumin-to-creatinine ratio that catches early kidney damage
same day
direct primary care visit access when glucose trends worsen

What the clinician actually manages

  • Oral agents like metformin and SGLT2 inhibitors, adjusted to your numbers and kidney function.
  • GLP-1 and dual GIP/GLP-1 therapy (semaglutide, tirzepatide) when weight and glucose both need to move — titrated slowly to limit nausea.
  • Blood pressure and lipids, because cardiovascular risk, not glucose alone, is what shortens lives in diabetes.
  • Continuous glucose monitor data, read as a trend line rather than a single fasting value.
Clinical note

Diabetes care is cardiovascular care. The targets that matter most are not glucose alone — they are blood pressure, LDL, and kidney markers. A model that only checks A1c is managing a number, not the disease.

Where insurance still does the heavy lifting

Direct primary care does not cover insulin at the pharmacy counter, an endocrinology referral for complex type 1 or brittle diabetes, retinal screening by an ophthalmologist, or a hospitalization for diabetic ketoacidosis. Keep insurance for those. What the membership changes is the day-to-day management layer — the part where continuity and access decide whether your A1c drifts up or comes down.

Diabetes is not managed at the annual visit. It is managed in the weeks between them.

Who it fits

It fits adults with prediabetes who want to avoid progressing, and adults with type 2 diabetes who are actively adjusting therapy. It fits people who own a glucose monitor and want someone to actually read it. It fits less well for stable, well-controlled diabetes that genuinely needs only an annual check — though even then, the access is there when something changes. If your care needs GLP-1 therapy, GoodLife builds medical weight loss and metabolic management into the same membership rather than routing you to a separate program.

What the first 90 days usually look like

The opening phase of diabetes management in a direct primary care practice is deliberately hands-on. Visit one is long: a full history, a review of every medication, and baseline labs — A1c, a comprehensive metabolic panel, a fasting lipid panel, and a urine albumin-to-creatinine ratio. If you use a continuous glucose monitor, the clinician looks at the actual traces, not just the average, because the shape of your post-meal spikes tells them more than a single fasting number.

Weeks two through six are where continuity earns its keep. Rather than waiting for a quarterly recheck, your clinician adjusts therapy against real data: nudging metformin, adding an SGLT2 inhibitor for its cardiovascular and kidney benefit, or starting a low dose of a GLP-1 agent and titrating slowly to keep nausea manageable. Because messaging is included, a fasting glucose that will not come down is a two-line message and a same-week change, not a problem you sit on until the next appointment.

By the 90-day mark you recheck A1c to see the trend, confirm kidney function has not drifted, and set the monitoring cadence for the rest of the year. Blood pressure and LDL get targets of their own, because in type 2 diabetes the events that actually shorten lives are cardiovascular, not a single high glucose reading. The result of that first quarter is not a number on a chart — it is a plan you understand and a clinician who will keep adjusting it.

Where medication ends and habits begin

Medication moves glucose, but the durable gains in type 2 diabetes come from the parts of care that never fit into a rushed visit: protein and fiber targets, resistance training that improves insulin sensitivity, sleep, and alcohol. These are not motivational slogans — they are dose-modifying variables. A patient who adds two strength sessions a week and stabilizes their sleep often needs less medication to hit the same A1c, and a clinician with time can actually coach that rather than hand you a printout on the way out.

This is the quiet advantage of a membership model. Because your clinician is not billing per encounter, there is no penalty for a 15-minute message thread about why your morning readings climbed after a week of poor sleep, or a mid-month check on how a new eating pattern is landing. Diabetes is lived between appointments, and the model that stays in contact between appointments is the one that changes the trajectory.

Frequently Asked Questions

Is direct primary care good for diabetes management?

Yes, because type 2 diabetes needs frequent small adjustments, and direct primary care provides same-day access, direct messaging, and wholesale labs with the same clinician. That continuity tends to move A1c more effectively than rushed visits every few months.

Does direct primary care cover insulin and diabetes medications?

The membership covers the clinician relationship and often dispenses some generics at cost, but insulin and most prescriptions are filled at your pharmacy and covered by your drug plan. Keep insurance or Part D for medication coverage.

How often will I be seen for diabetes in direct primary care?

As often as the clinical situation requires, because there is no per-visit copay. A1c is typically rechecked about every three months while therapy is being adjusted, and you can message or be seen the same day when glucose trends worsen.

Can a direct primary care clinician prescribe GLP-1 medications for diabetes?

Yes. Direct primary care clinicians can prescribe GLP-1 and dual GIP/GLP-1 agents like semaglutide and tirzepatide, titrating the dose to limit side effects, when weight and glucose both need to improve.

Do I still need an endocrinologist with direct primary care?

Often no for straightforward type 2 diabetes, which primary care manages well. Complex type 1, brittle diabetes, or pump management may still warrant an endocrinologist, and your clinician coordinates that referral through your insurance.

Related guides

References

  1. Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/